This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
The National Postdoctoral Association (NPA) has appointed Henkel Valentine, Ph.D., as Diversity Committee vice chair.
Valentine is a postdoctoral scientist at Fox Chase Cancer Center in Philadelphia, PA. His research centers on developing advanced
CRISPR-based mouse models of bladder cancer that recapitulate mutations within the PI3K/AKT/mTOR signaling pathway, a frequently mutated axis in this cancer type. By precisely generating these genetic alterations, Valentine aims to identify effective
strategies for targeted treatment using kinase inhibitors, thereby establishing a foundation for potential clinical trials involving mTOR pathway inhibitors.
In addition to his scientific exploits, Valentine is actively involved in the Philadelphia community, where he coordinates programs designed to engage urban youth. Through these programs, he facilitates meaningful dialogues and hands-on experiences in
STEM, empowering young people to envision and pursue viable STEM careers.
Email to a Friend
Valentine is a postdoctoral scientist at Fox Chase Cancer Center in Philadelphia, PA. His research centers on developing advanced
CRISPR-based mouse models of bladder cancer that recapitulate mutations within the PI3K/AKT/mTOR signaling pathway, a frequently mutated axis in this cancer type. By precisely generating these genetic alterations, Valentine aims to identify effective
strategies for targeted treatment using kinase inhibitors, thereby establishing a foundation for potential clinical trials involving mTOR pathway inhibitors.